Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12533391 | Compositions and methods for the treatment of metabolic and liver disorders | 🖼🧊📄§ | 2026-01-27 | 2043-08-10 | 0 | 31 |
| 12533378 | Treatment of adverse effects caused by atypical antipsychotics | 🖼🧊📄§ | 2026-01-27 | 2040-05-10 | 0 | 31 |
| 12533400 | Zonal and targeted methods and uses for treating a chronic post-traumatic headache associated with a post-traumatic stress disorder | 🖼🧊📄§ | 2026-01-27 | 2045-06-30 | 0 | 31 |
| 12533364 | Methods and compositions for testosterone production | 🖼🧊📄§ | 2026-01-27 | 2045-05-30 | 0 | 31 |
| 12534461 | Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders | 🖼🧊📄§ | 2026-01-27 | 2043-07-19 | 0 | 31 |
| 12533431 | Treatment of CNS tumors | 🖼🧊📄§ | 2026-01-27 | 2040-03-11 | 0 | 31 |
| 12533329 | Compositions and methods of treatment with glutathione | 🖼🧊📄§ | 2026-01-27 | 2041-05-20 | 0 | 31 |
| 12534435 | Lipids and nanoparticle compositions thereof | 🖼🧊📄§ | 2026-01-27 | 2041-03-26 | 0 | 31 |
| 12533330 | (2S)-2-aminopentanethioic s-acid for use as medicament and in therapy of amyotrophic lateral sclerosis | 🖼🧊📄§ | 2026-01-27 | 2040-12-04 | 0 | 31 |
| 12533343 | Method for preparing (−)-cibenzoline succinate | 🖼🧊📄§ | 2026-01-27 | 2039-09-20 | 0 | 31 |
| 12533386 | Preparation of black tea extract with high theaflavin content and use thereof | 🖼🧊📄§ | 2026-01-27 | 2042-11-06 | 0 | 31 |
| 12533406 | Particles, DNA and RNA | 🖼🧊📄§ | 2026-01-27 | 2041-04-03 | 0 | 31 |
| 12533346 | Administration of berberine metabolites | 🖼🧊📄§ | 2026-01-27 | 2041-11-04 | 0 | 31 |
| 12534762 | Treating atopic dermatitis by targeting the WNT pathway | 🖼🧊📄§ | 2026-01-27 | 2039-09-27 | 0 | 31 |
| 12533379 | Application of TREM2hi macrophages in the preparation of drugs for the treatment of cardiac dysfunction | 🖼🧊📄§ | 2026-01-27 | 2042-11-06 | 0 | 31 |
| 12534470 | DNA polymerase IIIC inhibitors and use thereof | 🖼🧊📄§ | 2026-01-27 | 2043-04-11 | 0 | 31 |
| 12533385 | Use of mulberry twig alkaloids in preparation of drug for treating polycystic ovarian syndrome | 🖼🧊📄§ | 2026-01-27 | 2043-03-03 | 0 | 31 |
| 12533309 | Minoxidil adjuvant therapies | 🖼🧊📄§ | 2026-01-27 | 2042-06-10 | 0 | 31 |
| 12535491 | Vaccine comprising protein-targeted (PT) extracellular DNA isolated from bacterial matrix | 🖼🧊📄§ | 2026-01-27 | 2039-04-08 | 0 | 31 |
| 12533427 | Radioactive antitumor agent | 🖼🧊📄§ | 2026-01-27 | 2038-10-26 | 0 | 31 |
| 12534463 | Substituted tricyclic compounds as FGFR inhibitors | 🖼🧊📄§ | 2026-01-27 | 2043-10-20 | 0 | 31 |
| 12534515 | Broadly neutralizing anti-HIV-1 antibodies and methods of use thereof | 🖼🧊📄§ | 2026-01-27 | 2043-12-20 | 0 | 31 |
| 12533317 | Stem cell-derived exosomes containing pain regulators, and uses thereof | 🖼🧊📄§ | 2026-01-27 | 2041-04-07 | 0 | 31 |
| 12533334 | Compositions and methods for modulating equine fatty acid profiles | 🖼🧊📄§ | 2026-01-27 | 2044-06-17 | 0 | 31 |
| 12533352 | Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and salts thereof | 🖼🧊📄§ | 2026-01-27 | 2044-01-18 | 0 | 31 |
| 12534532 | CLL1-targeting antibody and application thereof | 🖼🧊📄§ | 2026-01-27 | 2039-10-28 | 0 | 31 |
| 12534478 | Prevention, prophylactic and therapeutic treatment of autoimmune diseases including multiple sclerosis using novel small molecules and compositions thereof | 🖼🧊📄§ | 2026-01-27 | 2043-09-08 | 0 | 31 |
| 12534519 | Molecules for therapy and diagnosis | 🖼🧊📄§ | 2026-01-27 | 2040-04-17 | 0 | 31 |
| 12534540 | CYP1A1-targeted monoclonal antibody with reactivity across vertebrate taxa | 🖼🧊📄§ | 2026-01-27 | 2044-01-23 | 0 | 31 |
| 12533365 | Fast absorbing trolamine salicylate formulations and compositions | 🖼🧊📄§ | 2026-01-27 | 2045-02-21 | 0 | 31 |
| 12533366 | Low dose therapeutic treatment | 🖼🧊📄§ | 2026-01-27 | 2043-10-12 | 0 | 31 |
| 12533335 | Monoglyceride use in animals | 🖼🧊📄§ | 2026-01-27 | 2044-07-18 | 0 | 31 |
| 12533353 | Methods of treatment of cancer comprising CDC7 inhibitors | 🖼🧊📄§ | 2026-01-27 | 2039-08-28 | 0 | 31 |
| 12533362 | Methods for treating diseases associated with ciliopathies | 🖼🧊📄§ | 2026-01-27 | 2038-10-12 | 0 | 31 |
| 12533342 | Methods of treating bacterial infections | 🖼🧊📄§ | 2026-01-27 | 2042-05-27 | 0 | 31 |
| 12533421 | Methods for making multilayered vesicles | 🖼🧊📄§ | 2026-01-27 | 2042-02-16 | 0 | 31 |
| 12534729 | Uses of synthetic lethal partners for treatment of cancer | 🖼🧊📄§ | 2026-01-27 | 2040-05-29 | 0 | 31 |
| 12534538 | Anti-HER2 binding molecules | 🖼🧊📄§ | 2026-01-27 | 2040-03-20 | 0 | 31 |
| 12534443 | Processes for preparing oxathiazin-like compounds | 🖼🧊📄§ | 2026-01-27 | 2044-05-06 | 0 | 31 |
| 12534512 | Human monoclonal antibodies to hantavirus and methods of use therefore | 🖼🧊📄§ | 2026-01-27 | 2040-11-10 | 0 | 31 |
| 12533361 | Use of polaprezinc in preparing drug for treating castration-resistant prostate cancer | 🖼🧊📄§ | 2026-01-27 | 2042-06-01 | 0 | 31 |
| 12534741 | Compositions and methods for treatment of neurological disorders | 🖼🧊📄§ | 2026-01-27 | 2043-07-19 | 0 | 31 |
| 12534495 | Compositions and methods for treating CNS disorders | 🖼🧊📄§ | 2026-01-27 | 2044-06-27 | 0 | 31 |
| 12533423 | Neuroprotective gene therapy targeting the AKT pathway | 🖼🧊📄§ | 2026-01-27 | 2040-03-03 | 0 | 31 |
| 12533370 | Compositions and methods of potentiating antimicrobials | 🖼🧊📄§ | 2026-01-27 | 2042-09-29 | 0 | 31 |
| 12533322 | Nanoparticle containing hydrophobic substance and manufacturing process and use thereof | 🖼🧊📄§ | 2026-01-27 | 2041-12-20 | 0 | 31 |
| 12533404 | Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases | 🖼🧊📄§ | 2026-01-27 | 2041-04-28 | 0 | 31 |
| 12534536 | Natural killer cells expressing a chimeric antigen receptor that binds CD38 | 🖼🧊📄§ | 2026-01-27 | 2040-08-31 | 0 | 31 |
| 12534521 | Antibodies specifically recognizing C5A and uses thereof | 🖼🧊📄§ | 2026-01-27 | 2041-06-18 | 0 | 31 |
| 12533393 | Vibrio cholerae protein for use against cancer | 🖼🧊📄§ | 2026-01-27 | 2040-10-09 | 0 | 31 |